COVID-19 Information

Edit Entry | Edit CV

Zbigniew M. Szczepiorkowski, MD, PhD

Professor of Pathology and Laboratory Medicine
Professor of Medicine

Pathology and Laboratory Medicine

1991 MD Medical Academy, Warsaw, Poland
1997 PhD Postgraduate Center of Medical Education, Warsaw, Poland

Immunology Program
Norris Cotton Cancer Center

Contact Information:

Department of Pathology and Laboratory Medicine
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon NH 03756

Office: Rubin 703
Phone: 603-650-7171
Fax: 603-650-4845

Assistant: Paula Martell
Asst. Phone: 603-650-7114
Asst. Email:

Professional Interests:

Translational research leading to introduction of novel cellular therapies applied broadly across the field of medicine.
Evidence based approach to the use of therapeutic apheresis in clinical practice.

Selected Publications:


Consensus International Council for Commonality in Blood Banking Automation-International Society for Cell & Gene Therapy statement on standard nomenclature abbreviations for the tissue of origin of mesenchymal stromal cells.
Viswanathan S, Ciccocioppo R, Galipeau J, Krampera M, Le Blanc K, Martin I, Moniz K, Nolta J, Phinney DG, Shi Y, Szczepiorkowski ZM, Tarte K, Weiss DJ, Ashford P
Cytotherapy. 2021 Jun 8; pii: S1465-3249(21)00644-7. doi: 10.1016/j.jcyt.2021.04.009. Epub 2021 Jun 8.
PMID: 34116944

Frozen Platelets-Development and Future Directions.
Kelly K, Cancelas JA, Szczepiorkowski ZM, Dumont DF, Rugg N, Dumont LJ
Transfus Med Rev. 2020 Oct;34(4):286-293. doi: 10.1016/j.tmrv.2020.09.008. Epub 2020 Sep 22.
PMID: 33317698

Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
Hubbard JA, Geno KA, Khan J, Szczepiorkowski ZM, de Gijsel D, Ovalle AA, AlSalman AS, Gallagher TL, Johnston AA, Tibbetts AR, Vital SE, Cervinski MA, Nerenz RD
J Appl Lab Med. 2021 Mar 1;6(2):429-440. doi: 10.1093/jalm/jfaa175.
PMID: 32976593

Indications for therapeutic apheresis in hematological disorders.
Szczepiorkowski ZM
Semin Hematol. 2020 Apr;57(2):57-64. doi: 10.1053/j.seminhematol.2020.07.008. Epub 2020 Jul 25.
PMID: 32892844

A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study.
Boada M, Lopez OL, Olazaran J, Nuñez L, Pfeffer M, Paricio M, Lorites J, Piñol-Ripoll G, Gamez JE, Anaya F, Kiprov D, Lima J, Grifols C, Torres M, Costa M, Bozzo J, Szczepiorkowski ZM, Hendrix S, Paez A
Alzheimers Dement. 2020 Oct;16(10):1412-1425. doi: 10.1002/alz.12137. Epub 2020 Jul 27.
PMID: 32715623

A multicenter evaluation of heterogeneity in cellular therapy processing laboratory procedure times to assess workload capacity.
Thibodeaux SR, McKenna DH, Szczepiorkowski ZM, Fontaine MJ, Kelley L, Reems JA, Young PP, Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Transfusion. 2020 Aug;60(8):1811-1820. doi: 10.1111/trf.15899. Epub 2020 Jul 12.
PMID: 32654200

Variations in novel cellular therapy products manufacturing.
Fontaine MJ, Selogie E, Stroncek D, McKenna D, Szczepiorkowski ZM, Takanashi M, Garritsen H, Girdlestone J, Reems JA, Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Cytotherapy. 2020 Jun;22(6):337-342. doi: 10.1016/j.jcyt.2020.01.012. Epub 2020 Mar 27.
PMID: 32223996

What's in Your CART? Clinical insights on challenges in mononuclear cell collection for CAR-T therapy.
Annen K, Zubair A, Schwartz E, Schwartz J, Szczepiorkowski ZM
J Clin Apher. 2020 Jun;35(3):234-235. doi: 10.1002/jca.21776. Epub 2020 Mar 18.
PMID: 32186782

Postnatal intervention for the treatment of FNAIT: a systematic review.
Baker JM, Shehata N, Bussel J, Murphy MF, Greinacher A, Bakchoul T, Massey E, Lieberman L, Landry D, Tanael S, Arnold DM, Baidya S, Bertrand G, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Savoia H, Ryan G, Hume H, International Collaboration for Transfusion Medicine Guidelines (ICTMG).
J Perinatol. 2019 Oct;39(10):1329-1339. doi: 10.1038/s41372-019-0360-7. Epub 2019 Apr 10.
PMID: 30971767

Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress.
Boada M, Lopez O, Nuñez L, Szczepiorkowski ZM, Torres M, Grifols C, Paez A
Alzheimers Dement (N Y). 2019;5:61-69. doi: 10.1016/j.trci.2019.01.001. Epub 2019 Feb 26.
PMID: 30859122

View more publications on PubMed